17:28:46 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2025-02-14 Bokslutskommuniké 2024
2024-11-14 Kvartalsrapport 2024-Q3
2024-08-16 Kvartalsrapport 2024-Q2
2024-05-30 Årsstämma 2024
2024-05-17 Kvartalsrapport 2024-Q1
2024-03-01 Ordinarie utdelning CSMED 0.00 DKK
2024-02-14 Bokslutskommuniké 2023
2023-12-15 Ordinarie utdelning CSMED 0.00 DKK
2023-07-18 Kvartalsrapport 2023-Q3
2023-05-17 Kvartalsrapport 2023-Q2
2023-04-14 Extra Bolagsstämma 2023
2023-02-17 Kvartalsrapport 2023-Q1
2023-02-14 Årsstämma 2023
2023-02-10 Ordinarie utdelning CSMED 0.00 DKK
2022-11-18 Bokslutskommuniké 2022
2022-08-13 Kvartalsrapport 2022-Q3
2022-05-20 Kvartalsrapport 2022-Q2
2022-02-18 Kvartalsrapport 2022-Q1
2021-12-10 Ordinarie utdelning CSMED 0.00 DKK
2021-12-09 Årsstämma 2022
2021-11-18 Bokslutskommuniké 2021

Beskrivning

LandDanmark
ListaSpotlight DK
SektorHälsovård
IndustriLäkemedel & Handel
CS Medica är ett danskt medicintekniskt bolag, dedikerat till läkemedelsforskning, utveckling, tillverkning och global kommersialisering. Bolaget blandar vetenskap och natur för att förbättra patienters liv med cannabinoidterapier för smärtlindring, och för att hantera autoimmuna och stressrelaterade symtom. Globalt erbjuder CS Medica CBD-behandlingar över disk (OTC), inklusive patenterade medicinska produkter, MHRA och MDR-registrerade artiklar, under varumärket CANNASEN® eller med egen märkning.
2024-02-29 16:36:08

Today on February 29, 2024, in Copenhagen - CS MEDICA A/S ("CS MEDICA" or the "Company") held its annual general meeting ("AGM") at which the following principal resolutions were passed.

1. Election of chairman of the meeting
The board proposed Gitte Lund Henriksen as chairman of the meeting, which was unanimously accepted by the attendees.

The chairman confirmed that the convening of the Annual General Meeting (AGM) complied with the company's Articles of Association, as stipulated in section 5.1. Notice of the AGM was duly dispatched on the 14th of February 2024, meeting the requirements of section 5.2.

It was ascertained that the total number of voting shares stood at 8,899,282 (72%), out of a total share count of 12,322,635.

2. Presentation of the annual report with auditors' report for adoption
The AGM resolved in accordance with the Board of Directors' proposal, to approve the annual report presented during the AGM, with all votes represented at the AGM.

3. Resolution concerning the appropriation of profits or losses as recorded in the adopted annual report
The AGM resolved, in accordance with the Board of Directors' proposal, that the result for the period 1 October 2022 - 30 September 2023 (DKK - 14.512.764) is carried forward to the following year, with all votes represented at the AGM.

4. Election of members to the board of directors
The AGM resolved to replace two out of the four members on the board: Jørgen Flemming Ladefoged, and Karsten Adelmark. The vacant positions are now filled by Flemming Hegaard (https://advokatfirmaetfheegaard.dk/advokat_flemmingheegaard.html), Ib Madsen (https://www.linkedin.com/in/ib-madsen-5491983a/), and Jesper Halle (https://www.linkedin.com/in/jesper-herold-halle/), respectively, with Flemming Hegaard as Chairman of the Board. The decision was unanimously supported by all votes represented at the AGM.

5. Election of auditor
The AGM resolved, in accordance with the board of directors' proposal, that the existing auditor Christensen Kjærulff Statsautoriseret Revisionsaktieselskab was re-elected. The decision was supported by all votes represented at the AGM.

8. Any other business
The Chairman ascertained that no other business was to be discussed.